A 15-month prospective study of 109 patients with the acquired immune deficiency
syndrome (AIDS) or AIDS-related complex (ARC) was conducted. Cytomegalovirus (CMV) …

Purpose: To examine the clinical outcomes achieved by using intravitreal ganciclovir
injections combined with systemic anti-viral therapy in treating cytomegalovirus (CMV) …

To assess the effect of intravenous cidofovir on delaying progression of previously treated,
relapsing cytomegalovirus (CMV) retinitis, we conducted a randomized, controlled …

Cytomegalovirus (CMV) retinitis is the most common cause of blind-ness in patients infected
with human immunodeficiency virus (HIV). Ganciclovir, a guanosine nucleoside, has been …

Induction regimens of foscarnet and ganciclovir are highly effective in arresting
cytomegalovirus (CMV) retinitis in patients with AIDS. Chronic maintenance therapy is …

Cytomegalovirus (CMV) encephalitis has been reported with increasing frequency in
patients with AIDS. Nevertheless, the management of CMV-related encephalitis appears to …

AIDS: The Food and Drug Administration (FDA) has approved oral ganciclovir (Cytovene) to
prevent initial episodes of CMV retinitis and other forms of CMV disease among individuals …

To investigate the role of antiviral drug resistance in cytomegalovirus (CMV) disease
progression, CMV cultured from an AIDS patient who developed progressive CMV disease …

Objective To study the safety of discontinuing cytomegalovirus (CMV) maintenance therapy
among patients with cured CMV retinitis receiving highly active antiretroviral therapy …

PURPOSE: To evaluate whether cytomegalovirus resistant to ganciclovir, detected in either
the blood or urine, correlates with adverse ocular outcomes. DESIGN: Prospective cohort …